About Us / MCC Multi-center Interest Group

MCC Multi-center Interest Group

Who we are

We are a group of 198 physicians, surgeons, pathologists, virologists, scientists and medical students based in medical institutions across the world who are committed to:

  • Promoting communication and collaborative studies on MCC.
  • Enhancing access to patient data and specimens.
  • Expanding evidence-based care for MCC.

Featured here are some of the current MMIG members. Click here to view more photos of MMIG members.

MMIG Meetings

Upcoming Meetings

Please save the date for the Annual Merkel cell carcinoma Multicenter Interest Group (MMIG) Meeting at the American Academy of Dermatology meeting in Washington, D.C. in March 2019.

When: Friday March 1, 2019 from 5-7 pm (EST)
Where: Marriott Marquis Washington DC; Room: Chinatown (no meeting registration required to attend; light refreshments included)
Topics Covered:

  • Steve Lu (Johns Hopkins):  “Which biomarker approach best predicts response to PD-(L)1 blockade: PD-L1 IHC, tumor mutation burden, gene expression profiling, or multiplex IHC/IF?”
  • David Miller (MGH) & Mike Wong (MD Anderson): “Project Data Sphere & collecting MCC patient outcomes data: Getting a noble goal to actually work”
  • Isaac Brownell (NIH): “How the paranuclear cytokeratin dot may be blocking apoptosis in MCC”
  • Michael Tetzlaff (MD Anderson): “T-cells and survival in Merkel cell carcinoma: Quantity and quality matter”
  • Chrysalyne Schmults (BWH) & Vishal Patel (George Washington University): “SCOUT (Skin Cancer OUTcomes) Consortium: Connecting physician experts in skin cancer with clinical trials”
  • Coley Doolittle-Amieva & Song Park (University of Washington): “The Merkel virus antibody test: Update on outcomes/performance and a practical guide for clinicians”

The meeting will be webcast via Zoom, details to follow.

Past Meetings

The MMIG meets yearly in various cities around the world. Click on a meeting year to access the summary of that year’s minutes.

Current MMIG Members

Click here to view photos of MMIG members.

Centers with established, multi-disciplinary MCC treatment programs are in BOLD. 

United States


  • Charite University Hospital, Berlin, Germany
  • Julius Maximilians University, Wuerzburg, Germany
  • Osaka City University School of Medicine, Osaka, Japan
  • Saga University Medical School, Saga, Japan
  • Sahlgrenska University Hospital, Gothenburg, Sweden
  • Sydney Melanoma Unit, Sydney, Australia
  • Tel Aviv University, Tel Aviv, Israel
  • Universidad Complutense, Madrid, Spain
  • Universidad Pontificia Bolivariana, Colombia, S America
  • University Hospital of Birmingham, Birmingham, UK
  • University of Sydney, Sydney, Australia
  • University of Turin, Turin, Italy
  • University of Versailles, Paris, France
  • Westmead Hospital, Sydney, Australia